Peripheral and central blockade of interleukin-6 trans-signaling differentially affects sleep architecture

Brain, Behavior, and Immunity

Volumn 50, Issue , 2015, Pages 178-185

  Oyanedel, Carlos N ^a,b   Kelemen, Eduard ^a   Scheller, Jürgen ^c   Born, Jan ^a   Rose John, Stefan ^d  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c Department of Orthopedic Surgery   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

Author keywords

IL 6 trans signaling; REM sleep; Sleep; Slow wave activity; Slow wave sleep; Theta rhythm

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 6; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); HYBRID PROTEIN; SGP130FC PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REM SLEEP; SIGNAL TRANSDUCTION; SLEEP; SLEEP DEPRIVATION; SLEEP SPINDLE; SLOW WAVE SLEEP; THETA RHYTHM; TRANSGENIC MOUSE; ANIMAL; BRAIN CORTEX; C57BL MOUSE; ELECTROENCEPHALOGRAPHY; GENETICS; IMMUNOLOGY; PHYSIOLOGY;

ANIMALS; CEREBRAL CORTEX; ELECTROENCEPHALOGRAPHY; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; SLEEP;

EID: 84936984931     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2015.07.001     Document Type: Article

References (39)

1. Benedict C., Scheller J., Rose-John S., Born J., Marshall L. Enhancing influence of intranasal interleukin-6 on slow-wave activity and memory consolidation during sleep. FASEB J. 2009, 23:3629-3636.
2. Besedovsky L., Lange T., Born J. Sleep and immune function. Eur. J. Physiol. 2012, 463:121-137.
3. Braun O., Dewitz C., Möller-Hackbarth K., Scheller J., Schiffelholz T., Baier P.C., Rose-John S. Effects of blockade of peripheral interleukin-6 trans-signaling on hippocampus-dependent and independent memory in mice. J. Interferon Cytokine Res. 2013, 33:254-260.
4. Brunello A.G., Weissenberger J., Kappeler A., Vallan C., Peters M., Rose-John S., Weis J. Astrocytic alterations in interleukin-6/soluble interleukin-6 receptor α double-transgenic mice. Am. J. Pathol. 2000, 157:1485-1493.
5. Burgos I., Richter L., Klein T., Fiebich B., Feige B., Lieb K., Voderholzer U., Riemann Increased nocturnal interleukin-6 excretion in patients with primary insomnia: a pilot study. Brain Behav. Immun. 2006, 20:246-253.
6. Buzsáki G. Theta oscillations in the hippocampus. Neuron 2002, 33:325-340.
7. Buzsáki G. Theta rhythm of navigation: link between path integration and landmark navigation, episodic and semantic memory. Hippocampus 2005, 15:827-840.
8. Campbell I.L., Erta M., Lim S.L., Frausto R., May U., Rose-John S., Scheller J., Hidalgo J. Trans-signaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain. J. Neurosci. 2014, 34:2503-2513.
9. Clinton J.M., Davis C.J., Zielinski M.R., Jewett K.A., Krueger J.M. Biochemical regulation of sleep and sleep biomarkers. J. Clin. Sleep Med. 2011, 7:S38-S42.
10. Dimitrov S., Lange T., Benedict C., Nowell M.A., Jones S.A., Scheller J., Rose-John S., Born J. Sleep enhances IL-6 trans-signaling in humans. FASEB J. 2006, 20:2174-2176.
11. Eschenko O., Mölle M., Born J., Sara S.J. Elevated sleep spindle density after learning or after retrieval in rats. J. Neurosci. 2006, 26:12914-12920.
12. Fischer M., Goldschmitt J., Peschel C., Brakenhoff J.P., Kallen K.J., Wollmer A., Grötzinger J., Rose-John S. A bioactive designer cytokine for human hematopoietic progenitor cell expansion. Nat. Biotechnol. 1997, 15:142-145.
13. Garcia-Oscos F., Peña D., Housini M., Cheng D., Lopez D., Borland M.S., Salgado R., Salgado H., D'Mello S., Kilgard M.P., Rose-John S., Atzori M. Vagal nerve stimulation block interleukin 6-dependent synaptic hyperexcitability induced by lipopolysaccharide-induced acute stress in the rodent prefrontal cortex. Brain Behav. Immun. 2015, 43:149-158.
14. Goehler L.E., Gaykema R.P.A., Hansen M.K., Anderson K., Maier S.F., Watkins L.R. Vagal immune-to-brain communication: a visceral chemosensory pathway. Auton. Neurosci. 2000, 85:49-59.
15. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Müller-Newen G., Schaper F. Principles of interleukin (IL)-6-type cytokine signaling and its regulation. Biochem. J. 2003, 374:1-20.
16. Hogan D., Morrow J.D., Smith E.M., Opp M.R. Interleukin-6 alters sleep of rats. J. Neuroimmunol. 2003, 137:59-66.
17. Imeri L., Opp M.R. How (and why) the immune system make us sleep. Nat. Rev. Neurosci. 2009, 10:199-210.
18. Jewett K.A., Krueger J.M. Humoral Sleep Regulation; interleukin-1 and tumor necrosis factor. Vitam. Horm. 2012, 89:241-257.
19. Jostock T., Müllberg J., Özbek S., Atreya R., Blinn G., Voltz N., Fischer M., Neurath M.F., Rose-John S. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur. J. Biochem. 2001, 268:160-167.
20. Krueger J.M. The role of cytokines in sleep regulation. Curr. Pharm. Des. 2008, 14:3408-3416.
21. Lange T., Dimitrov S., Born J. Effects of sleep and circadian rhythm on the human immune system. Ann. N.Y. Acad. Sci. 2010, 1193:48-59.
22. März P., Cheng J.G., Gadient R.A., Patterson P., Stoyan T., Otten U., Rose-John S. Sympathetic neurons can produce and respond to interleukin-6. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:3251-3256.
23. März P., Heese K., Dimitriades-Schmutz B., Rose-John S., Otten U. Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression. Glia 1999, 26:191-200.
24. May U., Schiffelholz T., Baier P.C., Krueger J.M., Rose-John S., Scheller J. IL-6-trans-signaling increases rapid-eye-movement sleep in rats. Eur. J. Pharmacol. 2009, 613:141-145.
25. Morrow J.D., Opp M.R. Sleep-wake behavior and responses of interleukin-6-deficient mice to sleep deprivation. Brain Behav. Immun. 2005, 19:28-39.
26. Morrow J.D., Opp M.R. Diurnal variation of lipopolysaccharide-induced alterations in sleep and body temperatures of interleukin-6-deficient mice. Brain Behav. Immun. 2005, 19:40-51.
27. Neckelmann D., Olsen O.E., Fagerland S., Ursin R. The reliability and functional validity of visual and semiautomatic sleep/wake scoring in the Møll-Wistar rat. Sleep 1994, 17:120-131.
28. Opp M.R., Obal F., Cady A.B., Johannsen L., Krueger J.M. Interleukin-6 is pyrogenic but not somnogenic. Physiol. Behav. 1989, 45:1069-1072.
29. Rabe B., Chalaris A., May U., Waetzig G.H., Seegert D., Williams A.S., Jones S.A., Rose-John S., Scheller J. Transgenic blockade of interleukin 6 transsignaling abrogates inflammation. Blood 2008, 111:1021-1028.
30. Riemann D., Kloepfer C., Berger M. Functional and structural brain alterations in insomnia: implications for pathophysiology. Eur. J. Neurosci. 2009, 29:1754-1760.
31. Rose-John S. IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. Int. J. Biol. Sci. 2012, 8:1237-1247.
32. Schmidt E.M., Linz B., Diekelmann S., Besedovsky L., Lange T., Born J. Effects of an interleukin-1 receptor agonist on human sleep, sleep-associated memory consolidation, and blood monocytes. Brain Behav. Immun. 2015, (Epub ahead of print).
33. Späth-Schwalbe E., Schrezenmeier H., Bornstein S., Burger K., Porzsolt F., Born J. Endocrine effects of recombinant interleukin 6 in man. Neuroendocrinology 1996, 63:237-243.
34. Späth-Schwalbe E., Hansen K., Schmidt F., Schrezenmeier H., Marshall L., Burger K., Fehm H.L., Born J. Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J. Clin. Endocr. Metab. 1998, 83:1573-1579.
35. Takahashi S., Kapás L., Fang J., Krueger J.M. Somnogenic relationships between tumor necrosis factor and interleukin-1. Am. J. Physiol. 1999, 276:R1132-R1140.
36. Vanderwolf C.H., Leung L.S. Hippocampal rhythmical slow activity: a brief history and effects of entorhinal lesions and phencyclidine. The Neurobiology of the Hippocampus 1983, 275-302. Academic Press, London. W. Seifert (Ed.).
37. Vgontzas A.N., Zoumakis M., Bixler E.O., Lin H.M., Prolo P., Vela-Bueno A., Kales A., Chrousos G.P. Impaired nighttime sleep in healthy old versus young adults is associated with elevated plasma interleukin-6 and cortisol levels: physiologic and therapeutic implications. J. Clin. Endocr. Metab. 2003, 88:2087-2095.
38. Vgontzas A.N., Bixler E.O., Lin H.M., Prolo P., Trakada G., Chrousos G.P. IL-6 and its circadian secretion in humans. NeuroImmunoModulation 2005, 12:131-140.
39. Whishaw I.Q., Vanderwolf C.H. Hippocampal EEG and behavior: changes in amplitude and frequency of RSA (theta rhythm) associated with spontaneous and learned movement patterns in rats and cats. Behav. Biol. 1973, 8:461-484.